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httpcense.Abstract Background: Cases of pleural effusion represent a great challenge for pulmonologists
and ultrasound is considered as an important tool for diagnosis of these cases.
Aim: To identify the role of percutaneous ultrasound guided needle biopsy in patients with undi-
agnosed pleural effusion.
Patients and methods: This study was conducted on 30 patients (26 males & 4 females) with undi-
agnosed pleural effusion using ultrasound guided pleural biopsies using a tru-cut needle. Diagnostic
yield, pathological tissue characterization, complications were recorded.
Results: The total number of diagnosed cases was 24 (80%); malignancies detected in 17 cases (9
as mesothelioma (30%), 8 as bronchogenic carcinoma with pleural metastasis (26.7%)), tuberculous
effusion in 2 cases (6.7%), inﬂammatory lung masses in 3 cases (10%), para-pneumonic effusion in
2 cases (6.7%) and 6 cases were not diagnosed (20%). In diagnosed cases tissues were classiﬁed
according to pathological characterization into pleural tissue in 4 cases (16.7%), pleural mass tissue
in 8 cases (33.3%), mixed pleural tissue and pleural mass tissue in 2 cases (8.3%) and mixed pleural
tissue with pleural and parenchymal mass tissue in 10 cases (41.7%). Complications were in the
form of bleeding at the site of procedure in 1 case (3.3%), shock in 1 case (3.3%) and pneumothoraxation biopsy; US, ultrasound;
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114 H.M. Bahr et al.in 2 cases (6.7%). Sensitivity, speciﬁcity and accuracy of ultrasound guided pleural biopsy were 80,
76 and 80% respectively.
Conclusions: Ultrasound-guided pleural biopsy is an effective and safe technique in patients with
undiagnosed pleural effusion. It allows accurate needle placement, shorter procedure time.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.Introduction
Exudative pleural effusions are frequently encountered in
pulmonary practice. [1] Determination of a speciﬁc diagnosis
can represent a major challenge. Pleural biopsy is indicated
to improve the diagnostic yield of unexplained pleural
effusion, particularly when pleural carcinomatosis or tuberculosis
is suspected [2].
Thoracic ultrasound (TUS) is a valuable clinical tool which
is increasingly being performed by chest physicians. In the UK,
guidelines have recently been published with suggested training
for physicians with an interest in practising TUS [3].
Blind pleural biopsies have varied sensitivities from 24% to
66% using Abrams needle. Complications of pneumothorax,
haemothorax and accidental breaking of needle have been de-
scribed [4].
Sensitivity index for pleural ﬂuid cytology is low and the
diagnostic yield improves when combined with pleural tissue,
examined histologically and cultured for mycobacteria [5].
Large vessels and aerated lung parenchyma can easily be
detected with ultrasound, which minimizes the risk of pneumo-
thorax and improves safety. US also can be performed at the
bedside and in any body position allowing for swift procedures
with minimal distress even in patients in poor general condi-
tion [6].
A prospective study found that US-assisted cutting-needle
biopsy performed by a pulmonologist is safe and effective in




This study was conducted on 30 patients (26 males & 4
females) their ages ranged from 32 to 86 years. All of them
were admitted in the chest department of Tanta University
Hospitals in the period from November 2010 to February
2012. Patients fulﬁlled the criteria of exudative pleural
effusions with uncertain diagnosis by routine radiological,
chemical, bacteriological and cytological methods. This study
was approved by the research ethics committee, Quality
assurance unit, Faculty of medicine, Tanta University.
Inclusion criteria
(1) Chest X-ray or CT chest or sonar evidence of pleural
effusion or pleural lesion.
(2) The cause of pleural effusion was not established by
chemical, bacteriological or cytological methods.
(3) Pleural lesion must be more than 2 cm in diameter if
present.Exclusion criteria
(1) Clinical or radiological features of empyema.
(2) Patients with transudative pleural effusion.
(3) Patients have bullous emphysema.
(4) Patients on anticoagulant therapy.
(5) Uncooperative patients.
The patients were subdivided into three groups
Group A: Patients with undiagnosed pleural effusion without
any underlying pleural or lung lesions. Group B: Patients with
undiagnosed pleural effusion with underlying pleural lesions
and without lung lesions. Group C: Patients with undiagnosed
pleural effusion with underlying pleural lesions and lung
lesions.Methods
(1) Thorough history taking and complete clinical
examination.
(2) Plain X-ray chest (P-A view), lateral view, thoracic
ultrasonography to demonstrate lesion site, size, possi-
bility of biopsy taking and CT chest if needed.
(3) Blood examination in the form of complete blood pic-
ture, erythrocyte sedimentation rate, coagulation time
and prothrombin time and activity.
(4) Tuberclin test.
(5) Sputum examination for acid fast bacilli and malignant
cells.
(6) Complete examination of pleural ﬂuid: Pleural ﬂuid was
taken by a disposable syringe in a clear dry tube. The
sample was taken by local subcutaneous injection of
xylocaine 2%. Aspiration of pleural ﬂuid was done by
a wide bore canula (18 G) at scapular line at the level
of most dullness by percussion and the following were
done: Protein, LDH, total and differential cell count,
Adenosine Deaminase, culture and sensitivity, cytologi-
cal examination and Zheil nelson of pleural ﬂuid.
(7) Ultrasound guided needle aspiration biopsy: Patient was
kept fasting at least 6 h before biopsy. A sterile ﬁeld
was created. The transducer which was used for biopsy
was the convex one with a frequency of 2–5 MHz.
Patient was allowed to sit exposing his back. Local anes-
thesia in the form of subcutaneous injection of xylocaine
2% is injected. Core biopsies of pleural or lung lesions
were performed using tru cut needle (Gauge 18) with a
specimen notch of 20 mm. In group A, the site for
biopsy taking was decided according to the area of pleu-
ral thickening present in CT scan.
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examined by means of US immediately after the proce-
dures for suspected pneumothoraces. Chest X-ray was
done for all patients. All patients were observed for at
least 1 h before discharge and complications were noted.
Results
This study was carried out on 30 patients. Their ages ranged
between 32–86 years with a mean value of 63.67 ± 14.19 years.
Number of patients less than 50 years was 5 (16.7%), number
of patients between 50–60 years was 7 (23.3%) and number of
patients more than 60 years was 18(60.0%). There were 26
males (86.7%) and 4 females (13.3%). Some pleural ﬂuid
parameters were shown in Table 1.
The patients were subdivided into 3 groups
 Group A: Included 7 (23.3%) patients with undiagnosed
pleural effusion without any apparent underlying pleural
or lung lesions. They were 6 males and 1 female, their ages
ranged between 32–83 years with mean value of 59 ± 21.44
years (Fig. 2).
 Group B: Included 10 (33.3%) patients with undiagnosed
pleural effusion with underlying pleural lesions and without
apparent lung lesion. They were 8 males and 2 females, their
ages ranged between 53–86 years with mean value
68.3 ± 11.59 years (Fig. 3).
 Group C: Included 13 patients with undiagnosed pleural
effusion with underlying pleural lesions and lung lesions
(43.3%). They were 12 males and 1 female, their ages ran-
ged between 42–80 years with mean value 62.62 ± 12.14
years (Fig. 4).Mesothelioma Bronchogenic carcinoma
Tberculous eﬀusion Inﬂammatory lung masses
para-pneumonic eﬀusion Undiagnosed
Figure 1 Histopathological diagnosis of all studied patients
(n= 30).Clinical presentations in the studied group
Clinical symptoms found in studied cases were in the form of
dyspnea in 27 (90.0%) cases, cough in 25 (83.3%) cases, expec-
toration in 14 (46.66%) cases, chest pain in 20 (66.7%) cases,
and haemoptysis in 4 (13.33%) cases.
Diagnostic yield of ultrasound guided biopsy
The total number of patients included in this study was 30 pa-
tients. The total number of diagnosed cases was 24 (80%).
Diagnoses established in group A were (4 patients out of 7)
57.1%, and in group B were (10 patients out of 10) 100% also
in group C were (10 patients out of 13) 76.9%.
Fig. 1 shows that the total number of diagnosed cases were
24 out of 30 patients; malignancies were detected in 17 cases (9
as mesothelioma (30%), 8 as bronchogenic carcinoma with
pleural metastasis (7 adenocarcinoma, 1 large cell carcinoma
(26.7%)), tuberculous effusion in 2 cases (6.7%), inﬂammatory
lung masses in 3 cases (10%), para-pneumonic effusion in 2
cases (6.7%) and 6 cases were not diagnosed (20%).
In group A the histopathological diagnosis was established
in 4 patients out of 7 (57.2%), 1 case as tuberculous effusion
(14.3%), 1 as mesothelioma (14.3%) and 2 as metastatic ade-
nocarcinoma (28.6%). In group B diagnosis was established
in 10 patients out of 10 (100%), 8 as mesothelioma (80%), 1case as tuberculosis effusion (10%) and 1 case as metastatic
adenocarcinoma (10%). In group C diagnosis was established
in 10 out of 13 patients (76.9%). 5 cases as bronchogenic car-
cinoma (50%) (4 adenocarcinoma and 1 large cell carcinoma),
3 cases as inﬂammatory lung masses (23.1%) and 2 cases as
parapneumonic effusion (20%).
Pathological tissue characterization
The total number of diagnosed cases was 24 (80%). Tissues
were classiﬁed according to pathological characterization into
pleural tissues in 4 cases (16.7%), pleural mass tissue in 8 cases
(33.3%), mixed pleural tissue and pleural mass tissue in 2 cases
(8.3%) and mixed pleural tissue with pleural and parenchymal
mass tissue in 10 cases (41.7%).
Complications of ultrasound guided transthoracic biopsy
were in the form of bleeding at the site of procedure in 1 case
(3.3%), shock in 1 case (3.3%) and pneumothorax in 2 cases
(6.7%).
The total number of established diagnosed cases was 24
with a sensitivity (80%), speciﬁcity (76%) and accuracy
(80%). Diagnosis was established in group A (4 patients out
of 7) with a sensitivity of 57.1%, of speciﬁcity (42%) and accu-
racy (65%), in group B (10 patients out of 10) with a sensitivity
(100%), speciﬁcity (100%) and accuracy (100%) and in group
C (10 patients out of 13) with a sensitivity (76.9%), speciﬁcity
(85%) and accuracy (75%) (Table 2).
Discussion
In recent years, chest physicians have come to appreciate US
as a quick bedside aid for assessing pleural effusions and assist-
ing thoracocentesis or chest drain placement. Ultrasound also
demonstrates pleural-based masses and lung tumors in the ab-
sence of a pleural effusion, provided they are involving or
abutting the pleura. Such lesions are suitable for cutting-needle
biopsy after the identiﬁcation of a puncture site with US,
which has distinct potential advantages in this setting [7].
This study assessed the safety and yield of US-assisted
transthoracic tru-cut needle biopsies in cases of undiagnosed
pleural effusion.
The most common symptoms in this study were dyspnea in
27 (90.0%) cases, cough in 25 (83.3%) cases, expectoration in
Figure 2 Ultrasound image of a case of an undiagnosed pleural
effusion without any underlying pleural or lung lesions.
Figure 3 Ultrasound image of a case of undiagnosed pleural
effusion with underlying pleural lesions and without lung lesions.
Figure 4 Ultrasound image of a case of undiagnosed pleural
effusion with underlying pleural lesions and lung lesions.
Table 1 Range, mean value of some pleural ﬂuid parameters
in the studied group.
Parameters Range Means ± SD.
Protein (g/dl) 3.1–5.6 4.3 ± 0.71
Glucose (mg/dl) 20–78 37.63 ± 14.43
LDH(IU/dl) 138–1460 415.9 ± 367.35
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ysis in 7 (23.3%) cases.
In agreement with the present study, Sahn et al. (1991) [8]
found that dyspnea and chest pain were the most common
symptoms in pleural effusion. In small pleural effusion patients
may have no symptoms but with massive pleural effusion
patients may have dyspnea at rest. Pleuritic chest pain is thecardinal symptom of pleural inﬂammation and is typically
accompanied by pleural effusion.
Dhital et al. (2009) [9] found that most common clinical
symptoms were in the form of shortness of breath (83%),
cough (67%) and fever (66%).
Pleural biopsy was taken by different needles such as tru-
cut needle, ﬁne needle and Abram’s needle. In the present
study, tru-cut needle was used in taking pleural biopsies as
Diacon et al. (2007) [10] who concluded that tru-cut needle
and ﬁne needle aspirated biopsies are complementary methods
for establishing a tissue diagnosis in patients with chest tumors
involving pleura.
US still has some advantages over CT and ﬂuoroscopy in
detecting and diagnosing pleural masses: (1) rapid and conve-
nient (2) detecting the pleural masses in real-time and making
needle biopsies simultaneously, and (3) no radiation exposure.
Practically, some patients with pleural masses and pleural effu-
sions often had complaints of dyspnea and chronic cough;
therefore, it was difﬁcult or impossible for these patients to
lie in bed for a thoracic CT examination or ﬂuoroscopic and
CT-guided needle biopsies [11].
In the present study, The total number of patients with
undiagnosed pleural effusion was 30; the total number of diag-
nosed cases was 24 (80%); malignancies detected in 17 cases (9
as mesothelioma (30%), 8 as bronchogenic carcinoma with
pleural metastasis (7 adenocarcinoma, 1 large cell carcinoma
(26.7%)), tuberculous effusion in 2 cases (6.7%), inﬂammatory
lung masses in 3 cases (10%), para-pneumonic effusion in 2
cases (6.7%) and 6 cases were not diagnosed (20%).
Some authors did a prospective study conducted on 34 pa-
tients with undiagnosed pleural effusion. The diagnostic yield
of pleural biopsies, mediastinal biopsies, peripheral lung biop-
sies and chest wall biopsies performed by a radiologist using
needle under ultrasound guidance was recorded, histological
results were analyzed. It was found that histopathological
diagnoses included primary or secondary carcinoma in
21(62%) patients; lymphoma in 4 (12%) patients; scar tissue
without tumor in 2(6%) patients with a history of lobectomy
for lung cancer; and, in 1(3%) patient each, plasmocytoma,
inﬂammatory pseudotumor, pneumonia, and lymphoid tissue,
(3) (8%) were not diagnosed [12].
Khosla et al. (2009) [13] studied 20 patients with undiag-
nosed pleura effusion, they performed ﬁne needle aspiration
biopsy (FNAB) under US guidance. It was found that US-
guided FNAB was able to diagnose 15 of 16 cases of non-small
cell carcinoma and 3 of 3 small cell carcinomas. In 1 patient
with benign lesion diagnosed as pneumonia after antibiotic
therapy.
The present study had a partial matching with Diacon et al.
(2004), [6] the difference may be due to large sample size and
that cases of pleural effusion were not enrolled, and with Khol-
sa et al. (2009) [13] which may be due to use of ﬁne needle,
Table 2 Sensitivity, speciﬁcity and accuracy of ultrasound
guided transthoracic pleural needle biopsy in the studied
groups.
Sensitivity% Speciﬁcity% Accuracy%
Group A 57.1 42 65
Group B 100 100 100
Group C 76.9 85 75
Total 80 76 80
Ultrasound guided needle pleural biopsy 117however it was not matching with Sheth et al. (1999), [12] may
be due to choosing US or CT for diagnosis with strict direction
of cases toward diagnostic object.
Lee et al. (2011) [14] studied 30 patients with undiagnosed
pleural effusion, the diagnostic yield of pleural biopsies per-
formed by respiratory physicians using a cutting needle under
ultrasound guidance was prospectively recorded. They found
that (13) patients showed evidence of deﬁnite malignancy,
the malignancies diagnosed included bronchogenic carcinoma
(6) (20%), mesothelioma (4) (13.3%) and metastatic adenocar-
cinoma (3) (10%), (1) (3.3%) biopsy demonstrated tuberculo-
sis, (3) (10%) showed chronic ﬁbrosis and (3) (10%) post
pneumonic pleural thickening. (2) (6.7%) patients with a neg-
ative pleural biopsies, (6) (20%) patients without pleural biop-
sies. This was matching with the present study, which may be
due to the equality of the number of cases in both studies.
In the present study the tissues were classiﬁed according to
pathological characterization into pleural tissue in 4 cases
(16.7%), pleural mass tissue in 8 cases (33.3%), mixed pleural
tissue and pleural mass tissue in 2 cases (8.3%) and parenchy-
mal tissue in 10 cases (41.7%) and 6 (20%) non diagnostic
biopsies.
Some authors described that deﬁnite parenchymal tissues
were found in 19 (56%) patients, pleural tissues in 6 (18%) pa-
tients, in 9 (26%) patients mediastinal and chest wall samples
and in 3 (10%) patients non diagnostic biopsies. (81).
Lee et al. (2011) [14] found that deﬁnite pleural tissue was
obtained in 22 (73%) patients, insufﬁcient pleural tissue in 2
(7%) patients and no pleural tissue in 6 (20%) patients.
The lower rate of adverse events during pleural biopsy tak-
ing in the present study conﬁrms that the lesion size and needle
type chosen in this study were adequate. US has the inherent
safety advantage of visualizing only lesions not shielded by
air-containing tissue. Aerated lung is therefore not transversed
with the biopsy device, which makes pneumothorax and air
embolus unlikely when a closed cutting-needle system is used.
Diacon et al. (2004) [6] found that 3 (3%) patients had
pneumothorax relived by chest tube insertion, 1 (1%) patient
with small wound required a single suture, 1 (1%) patient
developed dyspnea relieved by bronchodilators, Minor events
were transient pain requiring medication in 5 (5%) patients,
mild and transitory haemoptysis in 2 patients (2%) and vaso-
vagal reaction in 2 patients (2%).
In the present study, diagnosis was established in patients
of group A (4 patients out of 7) with a sensitivity of 57.1%,
speciﬁcity of 42% and accuracy of 65%, in patients of group
B (10 patients out of 10) with a sensitivity of 100%, speciﬁcity
of 100% and accuracy of 100.0% and in patients of group C
(10 patients out of 13) with a sensitivity (76.9%), speciﬁcity
(85%) and accuracy (75%).Diacon et al. 2004 [6] found that the sensitivity of the pro-
cedure for neoplastic disease was 85.5% and 100% for malig-
nant mesothelioma.
Khosla et al. 2009 [13] found that the sensitivity of the pro-
cedure was 94.7%, 100% speciﬁcity, and 95% accuracy.
Kalhan et al. 2012 [15] studied 120 patients that presented
with thoracic mass lesions in the lungs, mediastinum, hilar
lymph nodes and pleura to compare the sensitivity and speci-
ﬁcity of CT scan and ultrasonography on thoracic FNAC.
They found that the sensitivity and speciﬁcity of ultrasound
guided FNAC was 93.2% and 100% respectively.
Lesions were considered suitable for US-guided biopsy if
they were in contact with chest wall for at least 2 cm regardless
of their size and location. Location behind a rib was consid-
ered to be a contraindication. Also, small lesions less than
2 cm or pleural effusion without underlying pleural masses
were found to be difﬁcult with a high failure rate in taking
the biopsy. So, this might be the cause of undiagnosed cases
in the present study especially most of the undiagnosed pa-
tients were in group A who had undiagnosed pleural effusion
without any underlying pleural or lung lesions.
However, the yield of 80% in the present study suggests
that US assistance might substitute CT guidance for lesions
P20 mm in diameter, irrespective of the presence of a pleural
effusion. Moreover, physician-operated US is far more acces-
sible than CT in many peripheral health-care facilities, and a
simple and low-cost diagnostic technique is particularly wel-
come in regions with high asbestos exposure.
This study had several limitations; the main one was limited
number of patients, excluding all patients with features of
empyema, systemic diseases, pulmonary diseases and there
were patients who refused invasive techniques. Other limita-
tion was that the pleural lesion must be more than 20 mm in
diameter.
Conclusions
US-guided transthoracic biopsy allows needle placement and
biopsy taking during a single breath hold, which decreases
the time the needle stays across the pleura with a multi planar
capability. Real-time US visualization allows accurate needle
placement, shorter procedure time, and performance in debil-
itated and less cooperative patients. Tru-cut needle is simple
with a high yield in patients with undiagnosed pleural diseases
especially for patients with pleural tumors, thickened pleura,
and small amount of pleural effusion.
Further studies are needed to evaluate the role of ultraso-
nography guided transthoracic biopsies including pleural and
lung lesions using cutting needles and ﬁne needle aspiration
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